Who
Bruce C. Cozadd
Director
Company insider
Files Form 4 as: Chairman & CEO, Jazz Pharmaceuticals; Director, Acelyrin; Director, Cerus; Director, Threshold Pharmaceuticals.
In numbers
- Trades disclosed
- 444
- Buys
- 1
- Sells
- 129
- Bought
- $86K
- Sold
- $106.7M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 3 Jan 2006
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.4M6,000 at $230.33 | filing |
| 1 Sep 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.5M6,000 at $250.13 | filing |
| 1 Sep 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.5M6,000 at $250.13 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $2,44110 at $244.06 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $292K1,209 at $241.39 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $2,44110 at $244.06 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $292K1,209 at $241.39 | filing |
| 5 Aug 2026filed 7 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,605 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,605 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.5M6,000 at $252.98 | filing |
| 3 Aug 2026filed 5 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.5M6,000 at $252.98 | filing |
| 1 Jul 2026filed 6 Jul 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.4M6,000 at $240.47 | filing |
| 1 Jul 2026filed 6 Jul 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.4M6,000 at $240.47 | filing |
| 1 Jun 2026filed 3 Jun 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.4M6,000 at $235.12 | filing |
| 1 Jun 2026filed 3 Jun 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.4M6,000 at $235.12 | filing |
| 1 May 2026filed 5 May 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.2M6,000 at $203.33 | filing |
| 1 May 2026filed 5 May 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.2M6,000 at $203.33 | filing |
| 1 Apr 2026filed 3 Apr 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $701K3,684 at $190.22 | filing |
| 1 Apr 2026filed 3 Apr 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $438K2,292 at $190.94 | filing |
| 1 Apr 2026filed 3 Apr 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $4,60224 at $191.74 | filing |
News
Jazz Pharmaceuticals gets Cramer's vote of confidenceJAZZ · aol.com · 14 Oct 2026Critical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ)JAZZ · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Bruce C. Cozadd; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.